

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.58172976 |
| 2 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.47206617 |
| 3 | protein neddylation (GO:0045116) | 4.96491055 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 4.92643682 |
| 5 | grooming behavior (GO:0007625) | 4.90167775 |
| 6 | regulation of female receptivity (GO:0045924) | 4.48270439 |
| 7 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.29889165 |
| 8 | purine nucleotide salvage (GO:0032261) | 4.24832847 |
| 9 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.24144015 |
| 10 | sleep (GO:0030431) | 4.23905158 |
| 11 | aggressive behavior (GO:0002118) | 4.23563365 |
| 12 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.20526173 |
| 13 | regulation of penile erection (GO:0060405) | 4.18576628 |
| 14 | GMP metabolic process (GO:0046037) | 4.09860426 |
| 15 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.88113757 |
| 16 | regulation of sensory perception (GO:0051931) | 3.82729538 |
| 17 | regulation of sensory perception of pain (GO:0051930) | 3.82729538 |
| 18 | negative regulation of heart rate (GO:0010459) | 3.77519097 |
| 19 | female mating behavior (GO:0060180) | 3.67198710 |
| 20 | plasma membrane fusion (GO:0045026) | 3.63617951 |
| 21 | positive regulation of glycolytic process (GO:0045821) | 3.60304842 |
| 22 | relaxation of smooth muscle (GO:0044557) | 3.45954656 |
| 23 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.44504321 |
| 24 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.43080666 |
| 25 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.43080666 |
| 26 | purine-containing compound salvage (GO:0043101) | 3.41848684 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.39315113 |
| 28 | response to gravity (GO:0009629) | 3.37891745 |
| 29 | maternal behavior (GO:0042711) | 3.37011443 |
| 30 | regulation of cilium movement (GO:0003352) | 3.33438347 |
| 31 | negative regulation of T cell apoptotic process (GO:0070233) | 3.26707266 |
| 32 | purinergic receptor signaling pathway (GO:0035587) | 3.26076179 |
| 33 | parental behavior (GO:0060746) | 3.24283898 |
| 34 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.22362136 |
| 35 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.21516766 |
| 36 | hyperosmotic salinity response (GO:0042538) | 3.21344838 |
| 37 | lipoxygenase pathway (GO:0019372) | 3.20090447 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17600819 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 3.17600819 |
| 40 | regulation of skeletal muscle contraction (GO:0014819) | 3.15574613 |
| 41 | regulation of catecholamine metabolic process (GO:0042069) | 3.14560682 |
| 42 | regulation of dopamine metabolic process (GO:0042053) | 3.14560682 |
| 43 | single strand break repair (GO:0000012) | 3.09541909 |
| 44 | regulation of platelet aggregation (GO:0090330) | 3.07203695 |
| 45 | regulation of platelet activation (GO:0010543) | 3.05577371 |
| 46 | adenosine metabolic process (GO:0046085) | 3.04611886 |
| 47 | regulation of thymocyte apoptotic process (GO:0070243) | 3.01848684 |
| 48 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.97184878 |
| 49 | blood coagulation, intrinsic pathway (GO:0007597) | 2.92446638 |
| 50 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.90786674 |
| 51 | branched-chain amino acid catabolic process (GO:0009083) | 2.89924825 |
| 52 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.89561773 |
| 53 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.86853008 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 2.86459075 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.86459075 |
| 56 | dopamine transport (GO:0015872) | 2.85555888 |
| 57 | regulation of megakaryocyte differentiation (GO:0045652) | 2.79577374 |
| 58 | negative regulation of response to food (GO:0032096) | 2.79297458 |
| 59 | negative regulation of appetite (GO:0032099) | 2.79297458 |
| 60 | cardiolipin metabolic process (GO:0032048) | 2.78610838 |
| 61 | regulation of norepinephrine secretion (GO:0014061) | 2.77866631 |
| 62 | polyamine biosynthetic process (GO:0006596) | 2.76744292 |
| 63 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.76195377 |
| 64 | branched-chain amino acid metabolic process (GO:0009081) | 2.72758954 |
| 65 | mitochondrial calcium ion transport (GO:0006851) | 2.72663189 |
| 66 | positive regulation of macrophage differentiation (GO:0045651) | 2.71716344 |
| 67 | regulation of lipoprotein metabolic process (GO:0050746) | 2.71470768 |
| 68 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.71331390 |
| 69 | platelet dense granule organization (GO:0060155) | 2.71009753 |
| 70 | regulation of relaxation of muscle (GO:1901077) | 2.70636985 |
| 71 | negative regulation of cation channel activity (GO:2001258) | 2.70014689 |
| 72 | ether lipid metabolic process (GO:0046485) | 2.69275737 |
| 73 | regulation of cholesterol efflux (GO:0010874) | 2.67071434 |
| 74 | microtubule depolymerization (GO:0007019) | 2.66949577 |
| 75 | DNA deamination (GO:0045006) | 2.61890064 |
| 76 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.61528427 |
| 77 | negative regulation of membrane potential (GO:0045837) | 2.61514812 |
| 78 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.61358201 |
| 79 | positive regulation of granulocyte differentiation (GO:0030854) | 2.60450447 |
| 80 | negative regulation of platelet activation (GO:0010544) | 2.59371782 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59171028 |
| 82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59171028 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 2.58410311 |
| 84 | monoamine transport (GO:0015844) | 2.55678851 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.55456614 |
| 86 | sulfation (GO:0051923) | 2.53254284 |
| 87 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52869403 |
| 88 | regulation of memory T cell differentiation (GO:0043380) | 2.52475171 |
| 89 | glucosamine-containing compound catabolic process (GO:1901072) | 2.52402651 |
| 90 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.52102185 |
| 91 | male meiosis (GO:0007140) | 2.50435115 |
| 92 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50424439 |
| 93 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50424439 |
| 94 | cell wall macromolecule metabolic process (GO:0044036) | 2.49474541 |
| 95 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.49095506 |
| 96 | activated T cell proliferation (GO:0050798) | 2.48816236 |
| 97 | multicellular organism reproduction (GO:0032504) | 2.48801312 |
| 98 | neuronal action potential propagation (GO:0019227) | 2.48087792 |
| 99 | behavioral response to nicotine (GO:0035095) | 2.47288386 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 2.46810771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.67459134 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.87325413 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.85473898 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.98582384 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.71864371 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25198548 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20440294 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11947572 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.10256251 |
| 10 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 2.05573313 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95748408 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95671700 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.95670017 |
| 14 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.93156213 |
| 15 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.82019974 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79235196 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76979320 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.74399270 |
| 19 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73893794 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68855393 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66255550 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66150670 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62267249 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61048496 |
| 25 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.56429083 |
| 26 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.56429083 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56001927 |
| 28 | AR_20517297_ChIP-Seq_VCAP_Human | 1.55743041 |
| 29 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.51367745 |
| 30 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.50810520 |
| 31 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.50810520 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48547894 |
| 33 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.44960082 |
| 34 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.39552277 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38594128 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34223734 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29805189 |
| 38 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28815591 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27392690 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26969899 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26242514 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.25514104 |
| 43 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.25393382 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24070433 |
| 45 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.22607040 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21112162 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21072578 |
| 48 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.19923721 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19443063 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19320655 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19076485 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18461645 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16501461 |
| 54 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.15202403 |
| 55 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.15066341 |
| 56 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14718112 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14349789 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13193299 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13187503 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12381443 |
| 61 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11306020 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10378078 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09739503 |
| 64 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09426420 |
| 65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09298755 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09277717 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.09136714 |
| 68 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.08945953 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08753619 |
| 70 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.08289898 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07868363 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07694671 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.06823956 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05681660 |
| 75 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05206710 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04607292 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03751179 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.03643522 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02965724 |
| 80 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.02677804 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02584907 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01310859 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00034047 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99631294 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99631294 |
| 86 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99324916 |
| 87 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98746928 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98510121 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97919189 |
| 90 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96951817 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96582652 |
| 92 | NFYB_21822215_ChIP-Seq_K562_Human | 0.95978205 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95807723 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94508413 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94471304 |
| 96 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93380204 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93355000 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92657642 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91857294 |
| 100 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90728560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.77772903 |
| 2 | MP0005646_abnormal_pituitary_gland | 3.65630943 |
| 3 | MP0003724_increased_susceptibility_to | 2.99093178 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.67619621 |
| 5 | MP0008004_abnormal_stomach_pH | 2.61205847 |
| 6 | MP0003646_muscle_fatigue | 2.59208100 |
| 7 | MP0005084_abnormal_gallbladder_morpholo | 2.53591018 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.46589580 |
| 9 | MP0009697_abnormal_copulation | 2.36530574 |
| 10 | MP0005410_abnormal_fertilization | 2.34983319 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.22269149 |
| 12 | MP0008872_abnormal_physiological_respon | 2.20151076 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.16461525 |
| 14 | MP0000230_abnormal_systemic_arterial | 2.12982752 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.11559913 |
| 16 | MP0002132_abnormal_respiratory_system | 2.04774441 |
| 17 | MP0001661_extended_life_span | 2.03194839 |
| 18 | MP0005083_abnormal_biliary_tract | 2.02573958 |
| 19 | MP0004084_abnormal_cardiac_muscle | 1.87322058 |
| 20 | MP0004036_abnormal_muscle_relaxation | 1.85992339 |
| 21 | MP0003186_abnormal_redox_activity | 1.83750537 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.83326726 |
| 23 | MP0010386_abnormal_urinary_bladder | 1.73747209 |
| 24 | MP0003787_abnormal_imprinting | 1.73119805 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.71108540 |
| 26 | MP0002102_abnormal_ear_morphology | 1.63829310 |
| 27 | MP0002736_abnormal_nociception_after | 1.63104042 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.52852023 |
| 29 | MP0003195_calcinosis | 1.51452335 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.48708466 |
| 31 | MP0000343_altered_response_to | 1.48358358 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.47876846 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.47687305 |
| 34 | MP0003879_abnormal_hair_cell | 1.46257820 |
| 35 | MP0009764_decreased_sensitivity_to | 1.42562450 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.41288564 |
| 37 | MP0001764_abnormal_homeostasis | 1.36550750 |
| 38 | MP0003718_maternal_effect | 1.36532610 |
| 39 | MP0003252_abnormal_bile_duct | 1.34563253 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.30146362 |
| 41 | MP0004147_increased_porphyrin_level | 1.29622088 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.25018111 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.22806534 |
| 44 | MP0003828_pulmonary_edema | 1.22430101 |
| 45 | MP0003638_abnormal_response/metabolism_ | 1.20643828 |
| 46 | MP0005535_abnormal_body_temperature | 1.20609373 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.16853562 |
| 48 | MP0003136_yellow_coat_color | 1.16689611 |
| 49 | MP0004134_abnormal_chest_morphology | 1.16664944 |
| 50 | MP0005332_abnormal_amino_acid | 1.16560242 |
| 51 | MP0003866_abnormal_defecation | 1.15880891 |
| 52 | MP0001756_abnormal_urination | 1.13311290 |
| 53 | MP0010329_abnormal_lipoprotein_level | 1.11793048 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.09960713 |
| 55 | MP0001970_abnormal_pain_threshold | 1.09010895 |
| 56 | MP0001542_abnormal_bone_strength | 1.07974165 |
| 57 | MP0004130_abnormal_muscle_cell | 1.07785567 |
| 58 | MP0005385_cardiovascular_system_phenoty | 1.06640733 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 1.06640733 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.06166889 |
| 61 | MP0000749_muscle_degeneration | 1.06121034 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.01224802 |
| 63 | MP0005647_abnormal_sex_gland | 0.97902320 |
| 64 | MP0001765_abnormal_ion_homeostasis | 0.97483750 |
| 65 | MP0010155_abnormal_intestine_physiology | 0.95419873 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 0.95317518 |
| 67 | MP0001663_abnormal_digestive_system | 0.94354791 |
| 68 | MP0005620_abnormal_muscle_contractility | 0.94111787 |
| 69 | MP0001905_abnormal_dopamine_level | 0.94107717 |
| 70 | MP0002735_abnormal_chemical_nociception | 0.91625680 |
| 71 | MP0002928_abnormal_bile_duct | 0.90828262 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.90602621 |
| 73 | MP0003880_abnormal_central_pattern | 0.89600762 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.89571885 |
| 75 | MP0002272_abnormal_nervous_system | 0.88589102 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.88477748 |
| 77 | MP0009046_muscle_twitch | 0.86866552 |
| 78 | MP0005670_abnormal_white_adipose | 0.86822797 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.85125603 |
| 80 | MP0004142_abnormal_muscle_tone | 0.85119017 |
| 81 | MP0001664_abnormal_digestion | 0.84267768 |
| 82 | MP0003075_altered_response_to | 0.82885957 |
| 83 | MP0005165_increased_susceptibility_to | 0.80777499 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.80706662 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.80456729 |
| 86 | MP0003436_decreased_susceptibility_to | 0.78714156 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75196683 |
| 88 | MP0002106_abnormal_muscle_physiology | 0.74240628 |
| 89 | MP0005448_abnormal_energy_balance | 0.73825466 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.73603213 |
| 91 | MP0003698_abnormal_male_reproductive | 0.73517677 |
| 92 | MP0004233_abnormal_muscle_weight | 0.71462550 |
| 93 | MP0004947_skin_inflammation | 0.71267704 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.69453868 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.69332737 |
| 96 | MP0005369_muscle_phenotype | 0.68426176 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.68391138 |
| 98 | MP0005266_abnormal_metabolism | 0.67586333 |
| 99 | MP0001502_abnormal_circadian_rhythm | 0.66984439 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.66310152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 5.64720104 |
| 2 | Petechiae (HP:0000967) | 5.25312153 |
| 3 | Menorrhagia (HP:0000132) | 4.85864657 |
| 4 | Increased mean platelet volume (HP:0011877) | 4.80179972 |
| 5 | Abnormal platelet volume (HP:0011876) | 4.47295922 |
| 6 | Dyschromatopsia (HP:0007641) | 4.39786010 |
| 7 | Nemaline bodies (HP:0003798) | 4.00321031 |
| 8 | Decreased central vision (HP:0007663) | 3.93615675 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.76245377 |
| 10 | Purpura (HP:0000979) | 3.67822500 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 3.60323699 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.53951607 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.49293495 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37176501 |
| 15 | Epistaxis (HP:0000421) | 3.32488163 |
| 16 | Muscle fiber splitting (HP:0003555) | 3.10891961 |
| 17 | Acute encephalopathy (HP:0006846) | 3.08413295 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.02613100 |
| 19 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.91006931 |
| 20 | Mitochondrial inheritance (HP:0001427) | 2.88454199 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.85814604 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 2.82267047 |
| 23 | Testicular atrophy (HP:0000029) | 2.73530044 |
| 24 | Hepatic necrosis (HP:0002605) | 2.65954369 |
| 25 | Hypothermia (HP:0002045) | 2.64375376 |
| 26 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.64041035 |
| 27 | Abnormal pupillary function (HP:0007686) | 2.63391164 |
| 28 | Myoglobinuria (HP:0002913) | 2.59973127 |
| 29 | Stomatitis (HP:0010280) | 2.56882555 |
| 30 | Facial diplegia (HP:0001349) | 2.54247549 |
| 31 | Hyperglycinuria (HP:0003108) | 2.51196560 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.48239843 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.48239843 |
| 34 | Abnormal protein glycosylation (HP:0012346) | 2.48239843 |
| 35 | Abnormal glycosylation (HP:0012345) | 2.48239843 |
| 36 | Central scotoma (HP:0000603) | 2.43684482 |
| 37 | Cerebral edema (HP:0002181) | 2.41833937 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.39501714 |
| 39 | Rimmed vacuoles (HP:0003805) | 2.36716367 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.35339331 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.35339331 |
| 42 | Hepatocellular necrosis (HP:0001404) | 2.30174589 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27581620 |
| 44 | Increased CSF lactate (HP:0002490) | 2.26335658 |
| 45 | Ketoacidosis (HP:0001993) | 2.26193673 |
| 46 | Gingival bleeding (HP:0000225) | 2.25648020 |
| 47 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.24550800 |
| 48 | Abnormal ciliary motility (HP:0012262) | 2.22588194 |
| 49 | Abnormality of macular pigmentation (HP:0008002) | 2.16499690 |
| 50 | Abnormality of the costochondral junction (HP:0000919) | 2.15875204 |
| 51 | Paralysis (HP:0003470) | 2.14969200 |
| 52 | Tongue fasciculations (HP:0001308) | 2.13556942 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.13350373 |
| 54 | Abnormal platelet function (HP:0011869) | 2.12242954 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.12242954 |
| 56 | Attenuation of retinal blood vessels (HP:0007843) | 2.10402818 |
| 57 | Abnormal auditory evoked potentials (HP:0006958) | 2.08527111 |
| 58 | Metaphyseal dysplasia (HP:0100255) | 2.04843264 |
| 59 | Weak cry (HP:0001612) | 2.02040868 |
| 60 | Shoulder girdle muscle weakness (HP:0003547) | 2.01419325 |
| 61 | Intellectual disability, profound (HP:0002187) | 2.01320929 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.00840953 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.00258018 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98542959 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98542959 |
| 66 | Anhidrosis (HP:0000970) | 1.98304794 |
| 67 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97447641 |
| 68 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97447641 |
| 69 | Pancreatic cysts (HP:0001737) | 1.97256602 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 1.95674114 |
| 71 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95114059 |
| 72 | Alveolar cell carcinoma (HP:0006519) | 1.93970277 |
| 73 | Ketosis (HP:0001946) | 1.93858649 |
| 74 | Tinnitus (HP:0000360) | 1.92982289 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 1.91440565 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 1.89271134 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89271134 |
| 78 | Difficulty climbing stairs (HP:0003551) | 1.89072476 |
| 79 | Type I transferrin isoform profile (HP:0003642) | 1.88827709 |
| 80 | Rhabdomyolysis (HP:0003201) | 1.88289059 |
| 81 | Keratoconus (HP:0000563) | 1.87861662 |
| 82 | Increased corneal curvature (HP:0100692) | 1.87861662 |
| 83 | Glucose intolerance (HP:0000833) | 1.87822765 |
| 84 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87419167 |
| 85 | Polydipsia (HP:0001959) | 1.86346055 |
| 86 | Abnormal drinking behavior (HP:0030082) | 1.86346055 |
| 87 | Areflexia of lower limbs (HP:0002522) | 1.86264718 |
| 88 | Exercise-induced myalgia (HP:0003738) | 1.86131053 |
| 89 | Scotoma (HP:0000575) | 1.82866426 |
| 90 | Optic disc pallor (HP:0000543) | 1.81705074 |
| 91 | Lethargy (HP:0001254) | 1.81650732 |
| 92 | Pelvic girdle muscle weakness (HP:0003749) | 1.81615573 |
| 93 | Respiratory failure (HP:0002878) | 1.81316064 |
| 94 | Abnormality of the corticospinal tract (HP:0002492) | 1.80727897 |
| 95 | Distal arthrogryposis (HP:0005684) | 1.80420975 |
| 96 | Muscle fibrillation (HP:0010546) | 1.77032364 |
| 97 | Exertional dyspnea (HP:0002875) | 1.76579320 |
| 98 | Mitral stenosis (HP:0001718) | 1.76163466 |
| 99 | Lactic acidosis (HP:0003128) | 1.75344986 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 1.74941062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.00848318 |
| 2 | MAP3K14 | 3.17736946 |
| 3 | TLK1 | 2.86265094 |
| 4 | MAP4K2 | 2.81140711 |
| 5 | MAPKAPK3 | 2.41828652 |
| 6 | MAP3K13 | 2.25365609 |
| 7 | BCKDK | 2.15508927 |
| 8 | EIF2AK3 | 2.12978615 |
| 9 | TBK1 | 2.10223348 |
| 10 | MYLK | 2.04847312 |
| 11 | IKBKB | 2.02247941 |
| 12 | IRAK1 | 1.97013560 |
| 13 | SCYL2 | 1.96354129 |
| 14 | OBSCN | 1.92407466 |
| 15 | STK16 | 1.87761096 |
| 16 | PIK3CG | 1.83398893 |
| 17 | MAP2K7 | 1.80553264 |
| 18 | IRAK2 | 1.79585025 |
| 19 | IKBKE | 1.77997042 |
| 20 | BMPR2 | 1.67767843 |
| 21 | FRK | 1.63588351 |
| 22 | TEC | 1.60862726 |
| 23 | DAPK2 | 1.60626954 |
| 24 | EIF2AK2 | 1.59394460 |
| 25 | BMX | 1.57368868 |
| 26 | GRK5 | 1.54347206 |
| 27 | EIF2AK1 | 1.49884291 |
| 28 | PTK2B | 1.48315491 |
| 29 | PHKG2 | 1.43509788 |
| 30 | PHKG1 | 1.43509788 |
| 31 | ZAK | 1.41950915 |
| 32 | MST4 | 1.38884155 |
| 33 | FLT3 | 1.33864673 |
| 34 | MAP3K12 | 1.30455155 |
| 35 | CAMKK2 | 1.20709218 |
| 36 | MAP3K6 | 1.19145977 |
| 37 | STK39 | 1.15096099 |
| 38 | ADRBK1 | 1.06945221 |
| 39 | ADRBK2 | 1.06844851 |
| 40 | PIK3CA | 1.02933348 |
| 41 | TNK2 | 0.99737139 |
| 42 | PINK1 | 0.98010729 |
| 43 | MAP3K7 | 0.97393746 |
| 44 | PLK2 | 0.95880947 |
| 45 | BTK | 0.94851726 |
| 46 | RIPK4 | 0.91056754 |
| 47 | ITK | 0.90768939 |
| 48 | ZAP70 | 0.89966415 |
| 49 | DAPK3 | 0.88899555 |
| 50 | NUAK1 | 0.87587980 |
| 51 | MAP2K1 | 0.86254219 |
| 52 | ILK | 0.83201926 |
| 53 | LMTK2 | 0.81727988 |
| 54 | VRK2 | 0.79242414 |
| 55 | IRAK4 | 0.77622044 |
| 56 | SYK | 0.76017744 |
| 57 | ABL2 | 0.75740971 |
| 58 | MAP2K2 | 0.74940146 |
| 59 | CSNK1G2 | 0.74069300 |
| 60 | CHUK | 0.71257789 |
| 61 | NTRK3 | 0.70982799 |
| 62 | BRSK2 | 0.70787423 |
| 63 | OXSR1 | 0.69441961 |
| 64 | MAPK13 | 0.67795319 |
| 65 | CSF1R | 0.64826433 |
| 66 | TIE1 | 0.63325876 |
| 67 | TXK | 0.61986482 |
| 68 | VRK1 | 0.61376033 |
| 69 | WNK4 | 0.60028313 |
| 70 | TAF1 | 0.59697111 |
| 71 | MAP3K5 | 0.59554082 |
| 72 | PLK3 | 0.57341899 |
| 73 | MAP3K2 | 0.57317721 |
| 74 | RPS6KA5 | 0.56943065 |
| 75 | EPHB2 | 0.56294365 |
| 76 | DAPK1 | 0.55421166 |
| 77 | FES | 0.55175078 |
| 78 | CDK19 | 0.54630389 |
| 79 | CSNK1G3 | 0.54343641 |
| 80 | KDR | 0.53838295 |
| 81 | PAK3 | 0.53678523 |
| 82 | GRK1 | 0.53473775 |
| 83 | NEK1 | 0.52362370 |
| 84 | TNIK | 0.49405670 |
| 85 | TRPM7 | 0.48757298 |
| 86 | BMPR1B | 0.47792384 |
| 87 | RET | 0.46680910 |
| 88 | PRKCQ | 0.45689671 |
| 89 | EPHA4 | 0.45550465 |
| 90 | CAMK1 | 0.43425897 |
| 91 | GRK6 | 0.43137823 |
| 92 | NME1 | 0.42250727 |
| 93 | MAP3K4 | 0.41218663 |
| 94 | EPHA3 | 0.40903553 |
| 95 | PBK | 0.40716563 |
| 96 | MUSK | 0.40404081 |
| 97 | ABL1 | 0.38526564 |
| 98 | MINK1 | 0.37869238 |
| 99 | CSNK1G1 | 0.37671249 |
| 100 | FER | 0.37523410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.12274832 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.02992387 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.94654714 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.91109738 |
| 5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.81473052 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.65006649 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.62278364 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28074472 |
| 9 | Platelet activation_Homo sapiens_hsa04611 | 2.25232045 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.19512462 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16025262 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.96878827 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96586163 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.90299725 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87862140 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.78579940 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.61192820 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59364305 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.53612683 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.52208345 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48261073 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44256075 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39300402 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39021267 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37823479 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37233620 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35692889 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32660089 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32422643 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32212246 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31916959 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.30827097 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29494236 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.29105119 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22873648 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.21953788 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21476911 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17572254 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15636339 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15212621 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10659366 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.09423784 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09135475 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08298347 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08237357 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06311392 |
| 47 | Alcoholism_Homo sapiens_hsa05034 | 1.05446750 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02766439 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96370846 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95833639 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95602825 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94936944 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94691099 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92761805 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91197167 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90116837 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89266668 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89090586 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86486267 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79483006 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78562864 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78176028 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76645096 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75190570 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72506087 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71282153 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71181308 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70702828 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.70436287 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.65787424 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.65706620 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62175088 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61274271 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.59532297 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55605712 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53365341 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50317618 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48219680 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45434253 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45117937 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.44617473 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43165325 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42628496 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.42232853 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39000333 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.37401712 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.37096332 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35038750 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33799097 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32701688 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31693971 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28825090 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28218809 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28062529 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.27699320 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27184463 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26464801 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.25892398 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25309757 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24954339 |

